Quantcast

CVS/Pharmacy Supports New Pediatric Dosing Directions for OTC Cough and Cold Products

October 7, 2008

WOONSOCKET, R.I., Oct. 7 /PRNewswire/ — CVS/pharmacy, the retail division of CVS Caremark Corporation, announced today that it will support the new pediatric dosing directions being implemented by the Consumer Health Products Association (CHPA), in consultation with the U.S. Food and Drug Administration (FDA) for certain oral over the counter (OTC) cough and cold products.

OTC cough and cold medicines for children are safe and effective when used as directed. As part of the industry’s overall commitment to educate parents and caregivers about responsibly using these medicines and to ensure that they have appropriate treatment choices for their children, CHPA has announced that manufacturers will voluntarily re-label certain oral OTC cough and cold products with new pediatric dosing directions to indicate that these medicines should not be taken by children under the age of four. Products with these new directions will be introduced throughout the 2008-09 cough and cold season.

CVS/pharmacy is working closely with its suppliers to ensure that these OTC medicines will be available in its stores with new pediatric dosing directions as quickly as possible. In the meantime, CVS will continue to keep the current versions of the 130 products it offers available for customers who rely on these medicines to treat their families’ cold and allergy symptoms.

“The health and safety of our customers is our highest priority and we support CHPA’s voluntary action,” said Michael Bloom, Senior Vice President of Merchandising at CVS/pharmacy. “As pediatric cough and cold medicines have been declared safe and effective by the FDA, it is also important that our customers have access to these products during cough and cold season while our suppliers transition to labels with new pediatric dosing directions.”

CVS/pharmacy will replace all affected items with the new versions as the re-labeled products become available. CVS will inform customers of the FDA’s recommendations and pending product label changes with prominent in-store signage in the cough and cold section. Customers are also encouraged to speak with their CVS pharmacist about potential treatment options for cold and allergy symptoms in children under age four.

For more information about safe dosing and the voluntary re-labeling of these products, please visit http://www.otcsafety.org/.

About CVS/pharmacy

CVS/pharmacy, the retail division of CVS Caremark Corporation , is America’s leading retail pharmacy with more than 6,300 retail locations. CVS/pharmacy is committed to improving the lives of those we serve by making innovative and high-quality health and pharmacy services safe, affordable and easy to access, both in its stores and online at CVS.com. General information about CVS/pharmacy and CVS Caremark is available at http://www.cvscaremark.com/.

CVS Caremark

CONTACT: Mike DeAngelis of CVS/pharmacy, +1-401-770-2645,mjdeangelis@cvs.com

Web site: http://www.cvscaremark.com/http://www.otcsafety.org/




comments powered by Disqus